Innospec Inc. carries a market capitalization of 2.31B, placing it among publicly traded companies globally. Its enterprise value stands at 1.81B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.31B |
| Enterprise Value | 1.81B |
Innospec Inc. currently has 24.63M shares outstanding.
| Shares Outstanding | 24.63M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Innospec Inc. trades at a trailing price-to-earnings ratio of 65.42. The price-to-sales ratio is 1.09, and the price-to-book ratio stands at 1.49.
| PE Ratio | 65.42 |
| PS Ratio | 1.09 |
| PB Ratio | 1.49 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | 14.57 |
| P/OCF Ratio | 16.21 |
On an enterprise value basis, Innospec Inc. trades at an EV/EBITDA multiple of 9.46 and an EV/FCF ratio of 13.05. The EV/Sales ratio of 0.98 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.08 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.98 |
| EV / EBITDA | 9.46 |
| EV / EBIT | 12.08 |
| EV / FCF | 13.05 |
Innospec Inc. maintains a current ratio of 2.78, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.78 |
| Quick Ratio | 1.79 |
| Debt / Equity | 3.55 |
| Debt / EBITDA | 0.25 |
| Interest Coverage | N/A |
Innospec Inc. posts a return on equity of 2.33 and a return on invested capital of 9.35.
| Return on Equity (ROE) | 2.33 |
| Return on Assets (ROA) | 1.69 |
| Return on Invested Capital (ROIC) | 9.35 |
| Return on Capital Employed (ROCE) | 2.18 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.96 |
Over the trailing twelve months, Innospec Inc. has paid 21.00M in income taxes, reflecting an effective tax rate of 14.65.
| Income Tax | 21.00M |
| Effective Tax Rate | 14.65 |
Innospec Inc.'s stock has gained approximately 13.15409% over the past 52 weeks. The 50-day moving average sits at 84.94, while the 200-day moving average is 79.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 13.15409% |
| 50-Day Moving Average | 84.94 |
| 200-Day Moving Average | 79.00 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Innospec Inc. generated 1.84B in revenue and converted that into 30.80M in net income, yielding earnings per share of 4.93. EBITDA reached 191.30M, while operating income came in at 149.80M.
| Revenue | 1.84B |
| Gross Profit | 505.90M |
| Operating Income | 149.80M |
| Pretax Income | 143.30M |
| Net Income | 30.80M |
| EBITDA | 191.30M |
| EBIT | 149.80M |
| Earnings Per Share (EPS) | 4.93 |
Innospec Inc. holds 250.20M in cash and equivalents against 47.90M in total debt, resulting in a net debt position of -250.20M. Total book value stands at 1.34B, with working capital of 656.60M providing operational flexibility.
| Cash & Cash Equivalents | 250.20M |
| Total Debt | 47.90M |
| Net Debt | -250.20M |
| Equity (Book Value) | 1.34B |
| Book Value Per Share | 54.54 |
| Working Capital | 656.60M |
Innospec Inc. produced 124.30M in operating cash flow over the past twelve months. After subtracting -14.40M in capital expenditures, free cash flow totaled 109.90M - equivalent to 4.44 per share.
| Operating Cash Flow | 124.30M |
| Capital Expenditures | -14.40M |
| Free Cash Flow | 109.90M |
| FCF Per Share | 4.44 |
Innospec Inc. operates with a gross margin of 27.46, reflecting its pricing power and cost economics. The operating margin of 8.13 and net profit margin of 1.67 provide insight into operational efficiency.
| Gross Margin | 27.46 |
| Operating Margin | 8.13 |
| Pretax Margin | 7.78 |
| Profit Margin | 1.67 |
| EBITDA Margin | 10.38 |
The company's payout ratio of 17.55 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.87 |
| Dividend Yield | N/A |
| Payout Ratio | 17.55 |
| Shareholder Yield | 3.31 |
| FCF Yield | 6.86 |
Innospec Inc.'s most recent stock split took place on July 23, 2007 with a 1:2 split ratio.
| Last Split Date | 7/23/2007 |
| Split Ratio | 1:2 |
Innospec Inc. posts an Altman Z-Score of 5.84, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.84 |